Trader’s Watch List : Compuware Corporation (NASDAQ:CPWR), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Origin Agritech Limited (NASDAQ:SEED), IntelliPharmaCeutics International Inc. (NASDAQ:IPCI), Marathon Oil Corporation (NYSE:MRO)

Levi & Korsinsky is investigating the Board of Directors of Compuware Corporation (NASDAQ:CPWR) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Thoma Bravo, LLC. Compuware Corporation (NASDAQ:CPWR) belongs to Technology sector. Its net profit margin is 9.40% and weekly performance is 15.29%. On last trading day company shares ended up $10.63. Compuware … Continue reading Trader’s Watch List : Compuware Corporation (NASDAQ:CPWR), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Origin Agritech Limited (NASDAQ:SEED), IntelliPharmaCeutics International Inc. (NASDAQ:IPCI), Marathon Oil Corporation (NYSE:MRO)

Stocks in Focus : MGM Resorts (NYSE:MGM), NPS Pharmaceuticals (NASDAQ:NPSP), LeMaitre Vascular (NASDAQ:LMAT), Range Resources (NYSE:RRC), BlackRock Maryland Municipal (NYSEMKT:BZM)

The Women’s Leadership Conference announces its 2014 program featuring two days of keynote speakers, breakout sessions, luncheons and networking opportunities. The conference, themed “Women Inspiring Women,” will be held Aug. 6 & 7 at the MGM Resorts International (NYSE:MGM) Grand Conference Center in Las Vegas. MGM Resorts International (NYSE:MGM)’s stock on 30 July traded at beginning with a price of $27.13and when day-trade ended the … Continue reading Stocks in Focus : MGM Resorts (NYSE:MGM), NPS Pharmaceuticals (NASDAQ:NPSP), LeMaitre Vascular (NASDAQ:LMAT), Range Resources (NYSE:RRC), BlackRock Maryland Municipal (NYSEMKT:BZM)

Morning Buzz – Yahoo! Inc. (NASDAQ:YHOO) , Reynolds American , Realogy (NYSE:RLGY) , NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) , ESB Financial Corporation (NASDAQ:ESBF)

Yahoo! Inc. (NASDAQ:YHOO) announced Monday it reached a definitive agreement to acquire six-year-old mobile analytics startup Flurry. Yahoo! Inc. (NASDAQ:YHOO) stock performance was -0.15% in last session and finished the day at $33.28. Traded volume was 18.43million shares in the last session and the average volume of the stock remained 19.69million shares. The beta of the stock remained 1.01. Yahoo! Inc. (NASDAQ:YHOO) insider ownership is … Continue reading Morning Buzz – Yahoo! Inc. (NASDAQ:YHOO) , Reynolds American , Realogy (NYSE:RLGY) , NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) , ESB Financial Corporation (NASDAQ:ESBF)

FB Nasdaq FB Facebook

Healthcare Active Stocks: AstraZeneca plc (ADR) (NYSE:AZN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD)

AstraZeneca Plc (ADR) (NYSE:AZN), in the headlines for spurning buyout offers from Pfizer Inc, aims to regain prominence in oncology with compelling trial results and a splashy exhibit booth at the world’s largest meeting of cancer doctors. AstraZeneca plc (ADR) (NYSE:AZN) stock performance was -0.83% in last session and finished the day at $72.76. Traded volume was 5.14million shares in the last session and the … Continue reading Healthcare Active Stocks: AstraZeneca plc (ADR) (NYSE:AZN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD)

FB Nasdaq FB Facebook

Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

BioScrip Inc (NASDAQ:BIOS), on May 8, 2014 announced 2014 first quarter financial results. First quarter revenue from continuing operations was $239.6 million and the net loss from continuing operations was $25.4 million, or $0.37 per basic and diluted share. Non-GAAP adjusted loss from continuing operations per basic and diluted share was $0.13.BioScrip Inc (NASDAQ:BIOS) stock performance was 17.08% in last session and finished the day … Continue reading Healthcare Gainers: BioScrip Inc (NASDAQ:BIOS), NPS Pharmaceuticals (NASDAQ:NPSP), RadNet Inc. (NASDAQ:RDNT), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)